Published in Drug Week, May 6th, 2005
The generation of trial data will conclude at the end of April after all enrolled patients complete the 30-day follow-up period. Biopure is hopeful that the clinical trial investigators will be able to present their preliminary study results in May at the late-breaking session of the EuroPCR conference in Paris.
The clinical trial was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week